Organon & Co | OGN - أرباح التشغيل

سعر السهم
9.13
التغيير اليومي
0.43 4.94%
شهريا
44.01%
سنويا
-15.81%
Q2 التوقعات
8.59




أرباح التشغيل تغيير تاريخ
Bristol-Myers Squibb USD 4.2B 562M 2025-12
Celltrion KRW 301.04B 58.57B 2025-09
Cspc Pharmaceutical CNY 206.26M 1.02B 2025-12
Deva Holding AS TRY 964.87M 240.32M 2023-09
Dianthus Therapeutics USD -69.54M 29.25M 2025-12
Divis Laboratories Ltd INR 7.72B 30M 2025-12
Gilead Sciences USD 2.96B 551M 2025-12
Glaxosmithkline GBP 2.3B 1.46B 2025-12
Kangmei Pharma CNY -26.7M 43.13M 2025-09
Knight Therapeutics CAD 6.21M 3.27M 2025-12
Laboratorios Farma EUR 135.05M 49.84M 2023-12
Malin Corporation EUR -1.1M 400K 2024-12
Medical Developments International AUD -36K 444K 2025-12
Merck USD 6.24B 318M 2025-12
Neuren Pharmaceuticals AUD 17.01M 11.56M 2025-12
Novartis USD 4.06B 521M 2025-12
Organigram Holdings CAD -20.13M 7.92M 2025-12
Organon & Co USD 388M 62M 2025-09
Ovoca Bio EUR -1.16M 4.48M 2025-06
Pharma Mar EUR 43.61M 47.57M 2025-12
Qiagen NV USD 121.88M 15.41M 2025-12
Sartorius EUR 150.1M 11.7M 2025-09
Sino Biopharmaceutical CNY 5.18B 3.32B 2025-06
Tilray USD -20.01M 9.34M 2025-09
Zealand Pharma A/S -707.05M 245.73M 2025-12